HEMP — Hempalta Income Statement
0.000.00%
- CA$5.22m
- CA$6.62m
- CA$0.54m
Annual income statement for Hempalta, fiscal year end - September 30th, CAD millions except per share, conversion factor applied.
2022 September 30th | 2023 September 30th | 2024 September 30th | |
---|---|---|---|
Period Length: | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS |
Status: | Final | Final | Final |
Revenue | |||
Total Revenue | 0 | 0 | 0.54 |
Cost of Revenue | |||
Gross Profit | — | — | -0.345 |
Selling / General / Administrative Expenses | |||
Depreciation and Amortization | |||
Unusual Expense / Income | |||
Total Operating Expenses | 0.45 | 0.067 | 5.32 |
Operating Profit | -0.45 | -0.067 | -4.78 |
Total Net Non Operating Interest Income / Expense | |||
Other Net Non Operating Costs | |||
Net Income Before Taxes | -0.443 | 0.058 | -6.5 |
Net Income After Taxes | -0.443 | 0.058 | -6.5 |
Minority Interest | |||
Net Income Before Extraordinary Items | |||
Net Income | -0.443 | 0.058 | -6.44 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||
Income Available to Common Shareholders Including Extraordinary Items | |||
Diluted Net Income | -0.443 | 0.058 | -6.44 |
Diluted Weighted Average Shares | |||
Basic EPS Including Extraordinary Items | |||
Diluted EPS Including Extraordinary Items | |||
Diluted EPS Excluding Extraordinary Items | |||
Normalised Income Before Taxes | |||
Normalised Income After Taxes | |||
Normalised Income Available to Common Shareholders | |||
Diluted Normalised EPS | -0.022 | 0.002 | -0.062 |